| BDA Clinical Trial demonstrates Bod's CBD Wafer superiority |
| 26/03/19 | PRICE SENSITIVE | | Share |
|
| BDA Bod progresses European expansion following LOI with Tilman |
| 11/03/19 | PRICE SENSITIVE | | Share |
|
| BDA Ceasing to be a substantial holder |
| 06/03/19 | | | Share |
|
| BDA Bod expands medicinal cannabis product suite |
| 01/03/19 | PRICE SENSITIVE | | Share |
|
| BDA Half Yearly Report and Accounts |
| 28/02/19 | PRICE SENSITIVE | | Share |
|
| BDA Bod continues to attract industry leading management |
| 19/02/19 | PRICE SENSITIVE | | Share |
|
| BDA Becoming a substantial holder |
| 12/02/19 | | | Share |
|
| BDA Becoming a substantial holder |
| 11/02/19 | | | Share |
|
| BDA Asia and Australian Roadshow Presentation |
| 06/02/19 | PRICE SENSITIVE | | Share |
|
| BDA Resignation of M Perrett as Director and Appendix 3Z |
| 22/01/19 | | | Share |
|
| BDA Appendix 3Y - George Livery and Jo Patterson |
| 17/01/19 | | | Share |
|
| BDA Quarterly Report and Appendix 4C |
| 16/01/19 | PRICE SENSITIVE | | Share |
|
| BDA Change of Director's Interest Notice |
| 17/12/18 | | | Share |
|
| BDA Ceasing to be a substantial holder |
| 03/12/18 | | | Share |
|
| BDA Appendix 3Y - Change of Director's Interest Notices |
| 28/11/18 | | | Share |
|
| BDA Section 708A Cleansing Notice |
| 28/11/18 | | | Share |
|
| BDA Appendix 3B |
| 28/11/18 | | | Share |
|
| BDA Bod Granted Licence to Export Medicinal Cannabis |
| 20/11/18 | PRICE SENSITIVE | | Share |
|
| BDA Results of Annual General Meeting |
| 19/11/18 | | | Share |
|
| BDA Audio interview with Bod Australia CEO Jo Patterson |
| 13/11/18 | | | Share |
|
| BDA Becoming a substantial holder |
| 12/11/18 | | | Share |
|
| BDA Bod has aligned with Chemist Warehouse Group |
| 09/11/18 | PRICE SENSITIVE | | Share |
|
| BDA Appendix 3B |
| 08/11/18 | | | Share |
|
| BDA Quarterly Report and Appendix 4C |
| 31/10/18 | PRICE SENSITIVE | | Share |
|
| BDA Bod secures first medicinal cannabis prescription |
| 25/10/18 | PRICE SENSITIVE | | Share |
|
| BDA Annual Report to shareholders |
| 19/10/18 | | | Share |
|
| BDA Appendix 4G and Corporate Governance Statement |
| 19/10/18 | | | Share |
|
| BDA Notice of Annual General Meeting/Proxy Form |
| 18/10/18 | | | Share |
|
| BDA Investor Presentation |
| 18/10/18 | | | Share |
|
| BDA Bod Achieves Word First in Phase 1 Clinical Trial |
| 16/10/18 | PRICE SENSITIVE | | Share |
|
| BDA Becoming a substantial holder |
| 15/10/18 | | | Share |
|
| BDA S708A Cleansing Notice |
| 09/10/18 | | | Share |
|
| BDA Restricted securities to be released from escrow |
| 08/10/18 | | | Share |
|
| BDA Appendix 3B |
| 08/10/18 | | | Share |
|
| BDA Becoming a substantial holder |
| 04/10/18 | | | Share |
|
| BDA Bod Completes $6.4m Strategic Placement |
| 28/09/18 | PRICE SENSITIVE | | Share |
|
| BDA Trading Halt |
| 26/09/18 | PRICE SENSITIVE | | Share |
|
| BDA Bod and Lambert Initiative enter research collaboration |
| 25/09/18 | PRICE SENSITIVE | | Share |
|
| BDA Mamacare distribution agreement with Priceline Pharmacy |
| 19/09/18 | PRICE SENSITIVE | | Share |
|
| BDA Initial Directors Interest Notice - Mr Stephen Thompson |
| 06/09/18 | | | Share |
|
| BDA Initial Directors Interest Notice - Mr George Livery |
| 06/09/18 | | | Share |
|
| BDA Company Secretary Appointment/Resignation |
| 05/09/18 | | | Share |
|
| BDA Appendix 4E and Audited Financial Statements |
| 31/08/18 | PRICE SENSITIVE | | Share |
|
| BDA Appointment of Mr Stephen Thompson as Executive Director |
| 21/08/18 | | | Share |
|
| BDA Appendix 3B |
| 07/08/18 | | | Share |
|
| BDA Quarterly Report and Appendix 4C |
| 31/07/18 | PRICE SENSITIVE | | Share |
|
| BDA Results of General Meeting |
| 24/07/18 | | 78.67KB | Share |
|
| BDA Bod commences Phase I Clinical trial |
| 24/07/18 | PRICE SENSITIVE | 63.87KB | Share |
|
| BDA Notice of Extraordinary General Meeting & Proxy Form |
| 22/06/18 | | 290.62KB | Share |
|
| BDA Bod signs agreement with Symbion |
| 05/06/18 | PRICE SENSITIVE | 67.66KB | Share |
|
| BDA Ceasing to be a substantial holder |
| 04/06/18 | | 127.41KB | Share |
|
| BDA Becoming a substantial holder |
| 04/06/18 | | 138.98KB | Share |
|
| BDA Appointment of Executive Chairman |
| 30/05/18 | | 159.75KB | Share |
|
| BDA Appendix 3B & s708A Notice |
| 24/05/18 | | 490.66KB | Share |
|
| BDA Trial ready Cannabis Sublingual Wafer Formulation complete |
| 11/05/18 | PRICE SENSITIVE | | Share |
|
| BDA Change of Auditor |
| 01/05/18 | | | Share |
|
| BDA Cannabis Phase I Clinical Trial - Ethics Approval Received |
| 01/05/18 | PRICE SENSITIVE | | Share |
|
| BDA Quarterly Report and Appendix 4C |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| BDA Bod completes first order of medicinal cannabis oil |
| 12/04/18 | PRICE SENSITIVE | | Share |
|
| BDA Symbion to distribute Bod portfolio of natural medicines |
| 09/04/18 | PRICE SENSITIVE | | Share |
|
| BDA API to stock full Bod portfolio of natural medicines |
| 05/04/18 | PRICE SENSITIVE | | Share |
|
| BDA Bod Australia investor evening |
| 27/03/18 | | | Share |
|
| BDA Bod completes import of first cannabis products |
| 26/03/18 | PRICE SENSITIVE | | Share |
|
| BDA Investor Presentation |
| 02/03/18 | | | Share |
|
| BDA Bod delivers strong first half performance |
| 27/02/18 | | | Share |
|
| BDA Half Yearly Report and Accounts |
| 27/02/18 | PRICE SENSITIVE | | Share |
|
| BDA Bods exclusive partner iX Biopharma secures China patent |
| 26/02/18 | PRICE SENSITIVE | | Share |
|
| BDA Bod to commence importing medicinal cannabis oil |
| 23/02/18 | PRICE SENSITIVE | | Share |
|
| BDA Agreement with In2pharma & expansion of Health Product range |
| 14/02/18 | PRICE SENSITIVE | | Share |
|
| BDA Bod commences import of cannabis products |
| 05/02/18 | PRICE SENSITIVE | | Share |
|
| BDA Quarterly Report and Appendix 4C |
| 24/01/18 | PRICE SENSITIVE | | Share |
|
| BDA Agreement to develop Hemp Manuka Honey Product Line |
| 18/01/18 | PRICE SENSITIVE | | Share |
|
| BDA Update on Fast Track of Phase I Clinical Trials |
| 11/01/18 | | | Share |
|
| BDA Agreement with iX Biopharma Ltd |
| 04/01/18 | PRICE SENSITIVE | | Share |
|
| BDA S708A Cleansing Notice |
| 28/12/17 | | | Share |
|
| BDA Appendix 3B |
| 28/12/17 | | | Share |
|
| BDA S708A Cleansing Notice |
| 27/12/17 | | | Share |
|
| BDA Appendix 3B |
| 27/12/17 | | | Share |
|
| BDA Becoming a substantial holder |
| 22/12/17 | | | Share |
|
| BDA Bod Completes $3.2m Strategic Placement |
| 18/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Trading Halt |
| 14/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Strong growth and expansion of footprint into China |
| 13/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Reinstatement to Official Quotation |
| 08/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Bod Australia reinstated to Official Quotation |
| 08/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Medicinal Cannabis Import Licence Granted |
| 05/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Suspension from Official Quotation |
| 05/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Trading Halt |
| 01/12/17 | PRICE SENSITIVE | | Share |
|
| BDA Investor Presentation |
| 23/11/17 | | | Share |
|
| BDA Change of Director's Interest Notice - Mickey Perret |
| 21/11/17 | | | Share |
|
| BDA Appendix 3B - Issue of Unlisted Options |
| 17/11/17 | | | Share |
|
| BDA Results of Annual General Meeting |
| 15/11/17 | | | Share |
|
| BDA Bod begins formulating cannabis-based cosmetics products |
| 10/11/17 | PRICE SENSITIVE | | Share |
|
| BDA Pregnancy supplement distribution deal secured |
| 08/11/17 | PRICE SENSITIVE | | Share |
|
| BDA Restricted Securities to be released from Escrow |
| 27/10/17 | | | Share |
|
| BDA Quarterly Report & Appendix 4C |
| 27/10/17 | PRICE SENSITIVE | | Share |
|
| BDA Bod formalises Agreement with Linnea |
| 23/10/17 | PRICE SENSITIVE | | Share |
|
| BDA Annual Report with Chairman & CEO's address to Shareholders |
| 16/10/17 | | | Share |
|
| BDA Notice of Annual General Meeting & Proxy Form |
| 16/10/17 | | | Share |
|
| BDA Restricted Securities to be released from escrow |
| 05/10/17 | | | Share |
|
| BDA Research supports approach to medicinal cannabis extracts |
| 26/09/17 | PRICE SENSITIVE | | Share |
|
